Laing A, Richardson L Fronts and friends: social contingencies in the management of drug debt Sociol Q, 2024. Link

Fleming T, Boyd J, Chayama KL, Knight KR, McNeil R Using alone at home: What's missing in housing-based responses to the overdose crisis? Harm Reduct J, 2024. PubMed

Cui Z, Karamouzian M, Law M, Hayashi K, Milloy MJ, Kerr T The impact of longitudinal substance use patterns on the risk of opioid agonist therapy discontinuation: a repeated measures latent class analysis Int J Ment Health Addict, 2024. PubMed

Reddon H, Socías ME, DeBeck K, Hayashi K, Walsh Z, Milloy MJ Cannabis use to manage stimulant cravings among people who use unregulated drugs Addict Behav, 2024. PubMed

Kennedy MC, Dong H, Tobias S, Buxton J, Lysyshyn M, Tupper K, Ti L Fentanyl concentration in drug checking samples and risk of overdose death in Vancouver, Canada Am J Prev Med, 2024. PubMed

Tang X, Schalet BD, Janulis P, Keruly JC, Moore RD, Milloy MJ, DeBeck K, Hayashi K, Javanbakht M, Kim S, Siminski S, Shoptaw S, Gorbach PM Evaluating the agreement between different substance use recall periods in multiple HIV cohorts Drug Alcohol Depend, 2024. PubMed

Goodyear T, Chayama KL, Oliffe JL, Kia H, Fast D, Mniszak C, Knight R, Jenkins E Intersecting transitions among 2S/LGBTQ+ youth experiencing homelessness: a scoping review Child Youth Serv Rev, 2024. Link

Stehr R, Fast D, Naepi S, Knight R 'I turn to my closest friends for support': queer youth navigating mental health during COVID-19 Cult Health Sex, 2024. PubMed

Tobias S, Ferguson M, Palis H, Burmeister C, McDougall J, Liu L, Graham B, Ti L, Buxton JA Motivators of and barriers to drug checking engagement in British Columbia, Canada: findings from a cross-sectional study Int J Drug Policy, 2024. PubMed

Muir P, Nolan S Universal access to opioid agonist therapy in residential treatment settings: the time is now Can J Addict, 2023. Link